US antitrust case against GlaxoSmithKline over inhalers dismissed
MLex Summary: Counsel for Elliot C. Dale dismissed claims that GlaxoSmithKline used "device hopping" to obtain patent protection and regulatory exclusivities for its inhalers Ventolin and Arnuity Ellipta to stop other...To view the full article, register now.
Already a subscriber? Click here to view full article